IL68873A - Culture medium and methods for assessment of the nutritional status of individuals - Google Patents

Culture medium and methods for assessment of the nutritional status of individuals

Info

Publication number
IL68873A
IL68873A IL68873A IL6887383A IL68873A IL 68873 A IL68873 A IL 68873A IL 68873 A IL68873 A IL 68873A IL 6887383 A IL6887383 A IL 6887383A IL 68873 A IL68873 A IL 68873A
Authority
IL
Israel
Prior art keywords
individuals
assessment
methods
culture medium
nutritional status
Prior art date
Application number
IL68873A
Other languages
English (en)
Other versions
IL68873A0 (en
Original Assignee
Clayton Found Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Clayton Found Res filed Critical Clayton Found Res
Publication of IL68873A0 publication Critical patent/IL68873A0/xx
Publication of IL68873A publication Critical patent/IL68873A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5091Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Food Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Physiology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
IL68873A 1982-06-03 1983-06-02 Culture medium and methods for assessment of the nutritional status of individuals IL68873A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US38482282A 1982-06-03 1982-06-03
US06/492,308 US4499064A (en) 1982-06-03 1983-05-06 Assessment of nutritional status of individuals

Publications (2)

Publication Number Publication Date
IL68873A0 IL68873A0 (en) 1983-10-31
IL68873A true IL68873A (en) 1987-03-31

Family

ID=27010775

Family Applications (1)

Application Number Title Priority Date Filing Date
IL68873A IL68873A (en) 1982-06-03 1983-06-02 Culture medium and methods for assessment of the nutritional status of individuals

Country Status (18)

Country Link
US (1) US4499064A (fi)
EP (1) EP0096560B1 (fi)
KR (1) KR890000729B1 (fi)
AU (1) AU560934B2 (fi)
CA (1) CA1199883A (fi)
DE (1) DE3371362D1 (fi)
DK (1) DK172418B1 (fi)
ES (1) ES522980A0 (fi)
FI (1) FI77470C (fi)
GB (1) GB2124366B (fi)
HK (1) HK90188A (fi)
IE (1) IE55162B1 (fi)
IL (1) IL68873A (fi)
MX (1) MX161244A (fi)
NO (1) NO164252C (fi)
NZ (1) NZ204471A (fi)
PT (1) PT76808A (fi)
SG (1) SG57287G (fi)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5208039A (en) * 1985-12-19 1993-05-04 Centre National De La Recherche Scientifique (Cnrs) Nutrient compositions deprived of methionine and supplemented with homocysteine
GB8900924D0 (en) * 1989-01-17 1989-03-08 Amco Chemie Handel Compositions for use in enzyme deficiencies
US5122469A (en) * 1990-10-03 1992-06-16 Genentech, Inc. Method for culturing Chinese hamster ovary cells to improve production of recombinant proteins
US20020032160A1 (en) * 1995-02-24 2002-03-14 Nyce Jonathan W. Compositions & formulations with an epiandrosterone or a ubiquinone & kits & their use for treatment of asthma symptoms & for reducing adenosine/adenosine receptor levels
US5660835A (en) * 1995-02-24 1997-08-26 East Carolina University Method of treating adenosine depletion
US5985665A (en) * 1996-06-19 1999-11-16 Research Development Foundation Biochemical analysis of antioxidant function of lymphocytes in culture
TW517089B (en) 1996-09-03 2003-01-11 Res Dev Foundation Assessment of intracellular cysteine and glutathione concentrations
AU4195899A (en) * 1998-05-21 1999-12-06 Roger Davis Deutsch Patient-controlled lymphocyte method for detecting nutrient deficiency
US7136820B1 (en) * 1999-11-22 2006-11-14 Advanced Medical Instruments Method/process of determining a personal dietary supplement profile and recommending dietary supplements for an individual
US20050070487A1 (en) * 2001-04-24 2005-03-31 Nyce Jonathan W. Composition, formulations and kit for treatment of respiratory and lung disease with non-glucocorticoid steroids and/or ubiquinone and a bronchodilating agent
WO2002085297A2 (en) * 2001-04-24 2002-10-31 East Carolina University Compositions & formulations with a non-glucocorticoid steroid &/or a ubiquinone & kit for treatment of respiratory & lung disease
US6723527B2 (en) 2001-10-26 2004-04-20 Board Of Regents, The University Of Texas System Methods for determining toxicity reversing agents
AU2003269889B2 (en) * 2002-06-17 2007-04-19 Epigenesis Pharmaceuticals, Llc Dihydrate dehydroepiandrosterone and methods of treating asthma or chronic obstructive pulmonary disease using compositions thereof
US7405207B2 (en) * 2002-06-17 2008-07-29 Epigenesis Pharmaceuticals, Inc. Nebulizer formulations of dehydroepiandrosterone and methods of treating asthma or chronic obstructive pulmonary disease using compositions thereof
US20090274676A1 (en) * 2003-07-31 2009-11-05 Robinson Cynthia B Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a pde-4 inhibitor for treatment of asthma or chronic obstructive pulmonary disease
US20090263381A1 (en) * 2003-07-31 2009-10-22 Robinson Cynthia B Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with an anti-ige antibody for treatment of asthma or chronic obstructive pulmonary disease
US20090285899A1 (en) * 2003-07-31 2009-11-19 Robinson Cynthia B Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a methylxanthine derivative for treatment of asthma or chronic obstructive pulmonary disease
US20090297611A1 (en) * 2003-07-31 2009-12-03 Robinson Cynthia B Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a tyrosine kinase inhibitor, delta opioid receptor antagonist, neurokinin receptor antagonist, or vcam inhibitor for treatment of asthma or chronic obstructive pulmonary disease
US20050026883A1 (en) * 2003-07-31 2005-02-03 Robinson Cynthia B. Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a PDE-4 inhibitor for treatment of asthma or chronic obstructive pulmonary disease
US20050038004A1 (en) * 2003-07-31 2005-02-17 Robinson Cynthia B. Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with an anticholinergic bronchodilator for treatment of asthma or chronic obstructive pulmonary disease
US20050026884A1 (en) * 2003-07-31 2005-02-03 Robinson Cynthia B. Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a beta-agonist bronchodilator for treatment of asthma or chronic obstructive pulmonary disease
US20050026890A1 (en) * 2003-07-31 2005-02-03 Robinson Cynthia B. Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with an antihistamine for treatment of asthma or chronic obstructive pulmonary disease
US20050026880A1 (en) * 2003-07-31 2005-02-03 Robinson Cynthia B. Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a cromone for treatment of asthma or chronic obstructive pulmonary disease
US20050085430A1 (en) * 2003-07-31 2005-04-21 Robinson Cynthia B. Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a PDE-4 inhibitor for treatment of asthma or chronic obstructive pulmonary disease
US20050026879A1 (en) * 2003-07-31 2005-02-03 Robinson Cynthia B. Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a tyrosine kinase inhibitor, delta opioid receptor antagonist, neurokinin receptor antagonist, or VCAM inhibitor for treatment of asthma or chronic obstructive pulmonary disease
US20050043282A1 (en) * 2003-07-31 2005-02-24 Robinson Cynthia B. Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a lipoxygenase inhibitor for treatment of asthma or chronic obstructive pulmonary disease
US20050026882A1 (en) * 2003-07-31 2005-02-03 Robinson Cynthia B. Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a leukotriene receptor antagonist for treatment of asthma or chronic obstructive pulmonary disease
US20090285900A1 (en) * 2003-07-31 2009-11-19 Robinson Cynthia B Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a beta-agonist bronchodilator for treatment of asthma or chronic obstructive pulmonary disease
US20050101545A1 (en) * 2003-07-31 2005-05-12 Robinson Cynthia B. Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with an anticholinergic bronchodilator for treatment of asthma or chronic obstructive pulmonary disease
US20050026848A1 (en) * 2003-07-31 2005-02-03 Robinson Cynthia B. Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a methylxanthine derivative for treatment of asthma or chronic obstructive pulmonary disease
US20050026881A1 (en) * 2003-07-31 2005-02-03 Robinson Cynthia B. Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with an anti-IgE antibody for treatment of asthma or chronic obstructive pulmonary disease
US20050113318A1 (en) * 2003-07-31 2005-05-26 Robinson Cynthia B. Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a beta-agonist bronchodilator for treatment of asthma or chronic obstructive pulmonary disease
EP1824516A4 (en) * 2004-10-29 2008-11-05 Target Discovery Inc GLYCAN ANALYSIS WITH DEUTERATED GLUCOSE
WO2006127761A1 (en) * 2005-05-26 2006-11-30 Pediatrix Medical Group, Inc. Nutrition formulations and methods of providing nutrition formulations
US7838526B2 (en) * 2005-08-05 2010-11-23 Esther Baldinger Method of treating neurological disorders
CN101780083B (zh) * 2009-01-16 2012-01-25 海南四环医药有限公司 一种亚叶酸钙与苯丙氨酸的组合物及其制备方法
US20100210582A1 (en) * 2009-02-18 2010-08-19 Stewart Kendal L Method and composition for treating patients with a high risk of developing neuro-immune disorders or developmental delays, identified through the utilization of low homocysteine or its precursors/metabolites, as the predictor of such risk
LT2837680T (lt) 2011-07-01 2020-07-10 Amgen Inc. Žinduolių ląstelių kultūra
MX2020011614A (es) 2018-05-01 2020-12-09 Amgen Inc Anticuerpos con perfiles de glicanos modulados.

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US309985A (en) * 1884-12-30 Milk-can
US3128228A (en) * 1960-03-04 1964-04-07 Ustav Ser A Ockovacich Latek Tissue culture medium
US4282326A (en) * 1978-10-12 1981-08-04 Jeanne Moldenhauer Cell culture medium supplement
US4302437A (en) * 1979-08-30 1981-11-24 Victor Herbert Mitogen stimulated lymphocyte transformation
JPS57194787A (en) * 1981-05-28 1982-11-30 Ajinomoto Co Inc Culture medium for animal cell

Also Published As

Publication number Publication date
FI77470C (fi) 1989-03-10
PT76808A (en) 1983-07-01
GB2124366B (en) 1986-11-12
SG57287G (en) 1987-09-18
AU560934B2 (en) 1987-04-30
AU1536483A (en) 1983-12-08
US4499064A (en) 1985-02-12
NZ204471A (en) 1987-08-31
NO164252C (no) 1990-09-12
FI77470B (fi) 1988-11-30
KR840005012A (ko) 1984-11-03
DK254383A (da) 1983-12-04
NO164252B (no) 1990-06-05
HK90188A (en) 1988-11-18
IL68873A0 (en) 1983-10-31
ES8405953A1 (es) 1984-06-16
FI832005A0 (fi) 1983-06-03
IE831322L (en) 1983-12-03
GB8315287D0 (en) 1983-07-06
NO831985L (no) 1983-12-05
DK254383D0 (da) 1983-06-03
KR890000729B1 (ko) 1989-03-30
EP0096560B1 (en) 1987-05-06
IE55162B1 (en) 1990-06-20
EP0096560A1 (en) 1983-12-21
FI832005L (fi) 1983-12-04
CA1199883A (en) 1986-01-28
ES522980A0 (es) 1984-06-16
DE3371362D1 (en) 1987-06-11
DK172418B1 (da) 1998-06-02
MX161244A (es) 1990-08-24
GB2124366A (en) 1984-02-15

Similar Documents

Publication Publication Date Title
IL68873A0 (en) Culture medium and methods for assessment of the nutritional status of individuals
DE3274884D1 (en) Culture medium and its use
EP0073460A3 (en) Laminar batteries and methods of making the same
DE3276781D1 (en) Laminar batteries and methods of making the same
DE3477935D1 (en) An immoblized lipase preparation and use thereof
ZA857538B (en) Apparatus for the storage and release of information
EP0227245A3 (en) Recording medium and image formation process using the same
EP0258836A3 (en) Transfer recording medium and method of transfer recording using the same
JPS57168997A (en) Buffer medium and manufacture
EP0120658A3 (en) Method for identifying and characterizing organisms
EP0113319A3 (en) Cell lines and their use for the production of proteins
HK4294A (en) Recording medium and recording method utilizing the same
GB2099437B (en) Urethane copolymers and the method of their preparation
GB2124474B (en) Cookware and method of making the same
EP0245489A4 (en) AGRICULTURAL CHEMICALS PRODUCING ENDOSYMBIOTIC MICROORGANISMS AND THEIR PRODUCTION AND USE.
GB2102739B (en) Operation-indicating member and methods of manufacturing the same
EP0125468A3 (en) Agricultural-chemical-producing endosymbiotic bacteria and method of preparing and using same
IL65650A0 (en) Lysozyme-sensitive microorganisms and processes for the preparation thereof
IL63675A0 (en) Culture media and method of sterilizing the same
GB2078369B (en) Enzymatic assay method and apparatus
GB2146016B (en) Method for the preparation of haloacetals and halodioxolanes
DE3162049D1 (en) Method for the preparation of 2-halo-3-sulfonyl-acrylonitriles and their use
ZA834018B (en) Assessment of nutritional status of individuals
DE3368232D1 (en) Paper block and method of manufacturing the same
PL238935A1 (en) Laminate and method of making the same

Legal Events

Date Code Title Description
KB Patent renewed
KB20 Patent renewed for 20 years
EXP Patent expired